CSM Advisors LLC Increases Stock Holdings in Guardian Pharmacy Services, Inc. $GRDN

CSM Advisors LLC boosted its stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 40.9% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 135,665 shares of the company’s stock after acquiring an additional 39,360 shares during the quarter. CSM Advisors LLC’s holdings in Guardian Pharmacy Services were worth $3,559,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in GRDN. Brown Advisory Inc. raised its position in Guardian Pharmacy Services by 5.0% during the second quarter. Brown Advisory Inc. now owns 1,682,476 shares of the company’s stock worth $35,854,000 after acquiring an additional 79,652 shares during the period. Wellington Management Group LLP grew its position in shares of Guardian Pharmacy Services by 3.3% in the third quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company’s stock valued at $30,000,000 after purchasing an additional 36,072 shares during the period. Franklin Resources Inc. grew its position in shares of Guardian Pharmacy Services by 8.2% in the third quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company’s stock valued at $27,705,000 after purchasing an additional 80,033 shares during the period. Vanguard Group Inc. increased its stake in shares of Guardian Pharmacy Services by 9.1% during the third quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company’s stock worth $27,675,000 after purchasing an additional 88,296 shares in the last quarter. Finally, Boston Partners raised its position in shares of Guardian Pharmacy Services by 418.7% during the 3rd quarter. Boston Partners now owns 1,046,877 shares of the company’s stock worth $26,922,000 after purchasing an additional 845,048 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on GRDN shares. Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Truist Financial increased their target price on Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a “buy” rating in a report on Thursday. UBS Group restated a “buy” rating on shares of Guardian Pharmacy Services in a research report on Thursday. Raymond James Financial reaffirmed an “outperform” rating and issued a $40.00 price target on shares of Guardian Pharmacy Services in a research note on Thursday. Finally, Oppenheimer boosted their price target on Guardian Pharmacy Services from $35.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, March 12th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, Guardian Pharmacy Services presently has an average rating of “Moderate Buy” and an average price target of $38.00.

Guardian Pharmacy Services Trading Up 0.7%

Shares of NYSE GRDN opened at $32.83 on Tuesday. The stock has a market cap of $2.08 billion, a PE ratio of 42.64 and a beta of 0.85. Guardian Pharmacy Services, Inc. has a 12-month low of $19.17 and a 12-month high of $37.43. The company has a 50-day moving average of $31.96 and a 200 day moving average of $29.49.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Wednesday, March 11th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.10. The business had revenue of $397.62 million for the quarter, compared to analyst estimates of $390.04 million. Guardian Pharmacy Services had a net margin of 3.40% and a return on equity of 31.64%. The firm’s revenue for the quarter was up 17.4% compared to the same quarter last year. On average, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.